Preparation and Characterization of Curcumin Loaded Dextrin Sulfate- Chitosan Nanoparticles for Promoting Curcumin Anticancer Activity

Physicochemical properties of polymeric nanoparticles- curcumin

  • Nihal S Elbialy Associate Professor
Keywords: Curcumin, Dextren sulfate chitosan nanoparticles, physicochemical characterization, drug release profile, in vitro cytotoxicity

Abstract

Curcumin as a natural medicinal agent has been proved to kill cancer cells effectively. However, its biomedical applications have been hindered owing to its poor bioavailability. Many nanoparticulate systems have been introduced to overcome this problem. Among this types polymeric-based nanoparticles which exhibit unique properties allowing their use as a efficient drug carrier. Developing a polymeric- blend nanoparticles will offer a promising nanocarrier with excellent biocompatibility, biodegradability and low immunogencity.

In this study, curcumin nano-vehicle has been made up by combining dextren sulfate and chitosan (DSCSNPs). DSCSNPs have been characterized using different techniques. Transmission electron microscopy (TEM) which revealed the spherical, smooth surface of the nano-formulation. Dynamic light scattering (DLS) for measuring DSCSNPs hydrodynamic- diameter. Zeta potential measurements showed nanoparticles high stability. Fourier transform infrared spectroscopy (FTIR) confirmed  successful combination between the two polymers and curcumin loading on naoparticles surface. Curcumin release profile out of DSCSNPs showed high drug release in tumor acidic microenvironment. In vitro cytotoxicity measurements demonstrated that curcumin loaded polymeric nanoparticles (DSCSNPs-Cur) have high therapeutic efficacy against colon (HCT-116) and breast  (MCF-7) cancer cells compared with free curcumin.  DSCSNPs as a combined biopolymers is an excellent candidate for improving curcumin bioavailability  allowing its use as anticancer  agent.

Downloads

Download data is not yet available.

References

Aggarwal, B. B., Surh, Y. J., Shishodia, S., (2007). Advances in experimental medicine and biology. In The Molecular Target and Therapeutic Uses of Curcumin in Health and Disease, Eds.; Springer: New York, NY, USA, 2007.

Anand P., Sundaram C., Jhurani S., Kunnumakkara A. B., et al.(2008). Curcumin and cancer: an ‘Old-age’ disease with an ‘Age-old’ solution. Cancer Lett. 267: 133-164.

Marçal H., Wanandy N., Castellano-Gonzales G., Braidy N. (2012). Curcumin: Medicinal Properties, Molecular Targets and Biological Mechanisms. Sasaki J. and Kichida M. Curcumin: Biosynthesis, Medicinal Uses and Health Benefits. NOVA science publishers. 133:154.

Kuo C. L, Wu S. Y, Ip S. W, Wu P. P, et al., (2011). Apoptotic death in curcumin-treated NPC-TW 076 human nasopharyngeal carcinoma cells is mediated through the ROS, mitochondrial depolarization and caspase-3-dependent signaling responses. Int J Oncol., 39(2): 319-28.

Aggarwal B. B., Kumar A., Bharti. A. C. (2003). Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23: 363–398.

Ferguson J. E. and Orlando R. A.(2014). Curcumin Reduces Cytotoxicity of 5-Fluorouracil Treatment in Human Breast Cancer Cells. J Med Food. 1–6.

Wu S. H, Hang L. W, Yang J. S, Chen H. Y, et al., (2010).Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways. Anticancer Res. 30(6):2125-33.

Li P. M., Li Y. L., Liu B., Wang W. J., et al.,(2014). Curcumin Inhibits MHCC97H Liver Cancer Cells by Activating ROS/TLR-4/Caspase Signaling Pathway. Asian Pac J Cancer Prev. 15(5): 2329-34.

Lin Y. G., Kunnumakkara A. B., Nair A., Merritt w., et al.(2007). Curcumin Inhibits Tumor Growth and Angiogenesis in Ovarian Carcinoma by Targeting the Nuclear Factor-?B Pathway. Clin Cancer Res., 13: 3423.

Liu D. and Chen Z. (2013). The Effect of Curcumin on Breast Cancer Cells. J Breast Cancer .16 (2): 133-137.

Aggarwal, B.B. and Sung, B. (2009) Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol. Sci. 30, 85–94.

Sharma R.A., Euden S.A., Platton S. L., Cooke D. N., et al. (2004) Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance. Clin. Cancer Res., 10:6847 -6854.

Dhillon N, Aggarwal B. B, Newman R. A, Wolff R. A, et al. (2008) Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res ; 14: 4491-4499.

Shehzad A., Rehman G., Lee Y. S. (2013). Curcumin in Inflammatory Diseases. BioFactors. 39(1): 69-77.

Zou P., Helson L., Maitra A., Stern S T, and McNeil S.E. (2013). Polymeric Curcumin Nanoparticle Pharmacokinetics and Metabolism in Bile Duct Cannulated Rats. Mol Pharm., 10(5): 1977–1987.

Kurita T. and Makino Y. (2013). Novel Curcumin Oral Delivery Systems. Anticancer Res. 33: 2807-2822.

Rampinoa A, Borgognaa M, Blasib P, Bellicha B, et al.(2013) Chitosan nanoparticles: Preparation, size evolution and stability. International Journal of Pharmaceutic. 455 (1–2) , 219–228.

Das R., Kasoju N, Bora U. (2010). Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells Nanomedicine: Nanotechnology, Biology and Medicine. 6(1):153–160.

Zhoua N., Zanb X, Wang Z, Wud H , et al. (2013). Galactosylated chitosan–polycaprolactone nanoparticles for hepatocyte-targeted delivery of curcumin. Carbohydrate Polymers. 94: 420– 429.

Liu J, Xu L, Liu C, Zhang D, et al. (2012).Preparation and characterization of cationic curcumin nanoparticles for improvement of cellular uptake. Carbohyd Polym., 90:16-22.

Ghalandarlaki N., Alizadeh A. M., Ashkani-Esfahani S. (2014). Nanotechnology-Applied Curcumin for Different Diseases Therapy. BioMed Research International. 1-23.

Shao J., Zheng D., Jiang Z., Xu H., et al. (2011). Curcumin delivery by methoxy polyethylene glycol-poly(caprolactone) nanoparticles inhibits the growth of C6 glioma cells. Acta Biochim Biophys Sin (Shanghai). 43:267-74.

Anitha A., Deepagan V. G., Divya Rani V. V., Menon D., et al. (2011). Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate–chitosan nanoparticles. Carbohydrate Polymers. 84: 1158–1164.

Chen Y, Mohanraj V. J., Benson H. A. E, (2007). Designing chitosan-dextran sulfate nanoparticles using charge ratios, AAPS Pharm Sci Tech., 8(4): 131–139.

Antony V. Samrot, Ujjala Burman , Sheryl Ann Philip , Shobana N, Kumar Chandrasekaran, (2018). Synthesis of curcumin loaded polymeric nanoparticles from crab shell derived chitosan for drug delivery, Informatics in Medicine Unlocked 10: 159–182.

Lin W. C., Yu D. G.,Yang M. C. (2005). pH-sensitive polyelectrolyte complex gel microspheres composed of chitosan/sodium tripolyphosphate/dextran sulfate: Swelling kinetics and drug delivery properties. Colloids and Surfaces B: Biointerfaces. 44:143–151.

Gessner, A., Waicza, R., Lieske, A., Paulke, B. R., et al. (2000). Nanoparticles with decreasing surface hydrophobicities: Influence on plasma protein adsorption. International Journal of Pharmaceutics, 196:245–249.

Jayakumar, R., Reis, R. L., Mano, J. F. (2007). Synthesis and characterization of pH-sensitive thiol-containing chitosan beads for controlled drug delivery applications. Drug Delivery. 14: 9–17.

Published
2019-06-05
How to Cite
Elbialy, N. (2019). Preparation and Characterization of Curcumin Loaded Dextrin Sulfate- Chitosan Nanoparticles for Promoting Curcumin Anticancer Activity. JOURNAL OF ADVANCES IN PHYSICS, 16(1), 185-195. https://doi.org/10.24297/jap.v16i1.8276
Section
Articles